For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Everyday Health on MSN
Hypertrophic cardiomyopathy (HCM) and implantable devices: What to know about ICDs (and other options)
Two types of implantable cardioverter defibrillators can reduce the risk of sudden cardiac death with HCM. Pacemakers and implantable loop recorders also may be options.
Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
Please provide your email address to receive an email when new articles are posted on . An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.
Analysis results revealed racial and sex disparities among patients with hypertrophic cardiomyopathy who receive implantable cardioverter-defibrillator (ICD) devices. Among patients hospitalized with ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Subcutaneous implantable cardioverter ...
A cardiologist and electrophysiologist familiar with Boston Scientific's novel products bets one has a very bright future ahead. Arundhati Parmar Boston Scientific had a great 2014, and many Wall ...
The U.S. FDA has given its nod to Abbott Laboratories' next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The ...
Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...
ATLANTA, Oct. 6, 2020 /PRNewswire/ -- MedShape, Inc., the industry leader in orthopedic devices using advanced functional materials, today announced the U.S. Centers for Medicare & Medicaid Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results